ECOG-ACRIN EAY131-Q

Primary Category:

Treatment Protocols

Disease Category:

Molecular Profiling

Status:

Closed

MATCH Treatment Subprotocol Q: Ado-trastuzumab Emtansine in Patients with Tumors with HER2 Amplification (Except Breast and Gastric/Gastro-Esophageal Junction (GEJ) Adenocarcinomas)

 

(See required screening study ECOG-ACRIN EAY131)

NCT#02465060

Effective immediately, 06/15/18, EAY131-Q is formally closed to accrual, as it has reached its enrollment goal.